First RSV vaccine approved this month; more treatments on the horizon. You might have seen the news earlier this month: the U.S. has approved the first vaccine for respiratory syncytial virus (RSV),
A newly approved vaccine for older adults, as well as other potential treatments to protect infants, could make a monumental difference in the number of people being hospitalized and dying from RSV, infectious disease and public health experts say.